Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
|  | 
Georgia CTSA
Weekly eRoundup
June 26, 2020
|
| |
| | | | | The Georgia CTSA Evaluation and Continuous Improvement (ECI) program recently completed a study providing greater insight into the range and depth of short-term influence and long-term impact made by a portfolio of 250 Georgia CTSA-supported pediatric publications. This evaluation of Georgia CTSA's pediatric research output found a body of work that is highly impactful compared to similar work by other institutions. The Georgia CTSA Pediatrics program ... | | | | Read More | | |
|
| |
| | | | | | Mark your calendar and join us in 2021 as we bring together researchers from across the region to present the best new clinical and translational research and build collaborative partnerships. More information, registration, and call for abstracts will be announced in the coming months. We are closely monitoring the COVID-19 pandemic and will make a decision later this year whether to proceed virtually or in person at Callaway Resort & Gardens. | | | | Read More | | |
|
| |
| | | | Congratulations to our alliance partner Morehouse School of Medicine on receiving this important HHS award to fight COVID-19 in racial and ethnic minority, rural, and socially vulnerable communities. | | | | Read More | | |
| |
| | | | The Woodruff Health Sciences Center (WHSC) announces the launch of the WHSC COVID-19 CENTER for URGENT RESEARCH ENGAGEMENT (COVID-19 CURE) and Awards Program, made possible by generous philanthropic support from the O. Wayne Rollins Foundation and the William Randolph Hearst Foundation. The CURE Center was created to facilitate high-impact science and discovery towards improved COVID-19 treatment and prevention research. The goal is to invest in high-impact Emory projects (e.g. in diagnostics, immunology, therapeutics, vaccines, seroprevalence, cohort development, disparities, computational studies and other clinical research) and smaller exploratory projects that can change the clinical course (effectively treat/prevent serious disease) or prevent the transmission and spread of this infection. The funds can be used to support new COVID-19 focused researchers, equipment/instrumentation, technical support, pilots and enhancing facilities for this work. In addition, COVID-19 CURE will act as a hub, facilitating and helping to prioritize Emory COVID-19 research activities. http://georgiactsa.org/documents/news/COVID-19-CURE.pdf. | | | | Read More | | |
| |
| | | | NIH has launched a four-pronged initiative, entitled Rapid Acceleration of Diagnostics, or RADx, to catalyze the scientific community to improve testing technologies, capacity, and accessibility for the country. As one of the four RADx components, RADx-Underserved Populations (RADx-UP) will establish a network of community-engaged projects to improve access to and acceptance of testing in underserved and vulnerable populations. The overarching goal of this $500M effort is to understand factors that have led to disproportionate burden of the pandemic on these populations, so that interventions can be implemented to decrease the disparities. Applications for this first phase will be accepted through August 2020 for FY20 funding. A second phase will be staggered to provide flexibility and to allow for adaption to the ever-changing needs that may be present as this pandemic evolves. Visit www.nih.gov/RADx to learn more. | | | | Read More | | |
| |
| | | | The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN). NIBIB will support the full range of product development including commercialization and product distribution. | | | | Read More | | |
| |
| | | | NIAID issued two funding opportunity announcements (FOAs) to support research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). The two FOAs are ideal for applicants proposing new coronavirus-related research projects. The scope and nature of your proposed research project should guide your decision whether to apply through the R01 or R21 FOA. They feature rolling submission, meaning you can apply as soon as it is ready and NIAID will review it in an expedited fashion. | | | | Read More | | |
| |
| | | | For up-to-date NIH COVID-19 information, including: Informational Videos; Proposal Submission & Award Management Resources; Human Subjects & Clinical Trials Guidance; Animal Welfare; Frequently Asked Questions regarding flexibilities for grantees and; Funding Opportunities, please visit the link below. | | | | Read More | | |
| |
| | | | The NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional) competition supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. Applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. Awards will be for up to $250,000 in direct costs per year, plus applicable Facilities and Administrative (F&A) costs. The maximum project period is 5 years. Please contact Holly Sommers (hsomme2@emory.edu) if you have any questions. | | | | Read More | | |
| |
| | | | This FOA solicits applications only to the COVID-19 public health emergency through support of the CARES Act. The NIH Director's Early Independence Award (a component of the High-Risk, High-Reward Research program of the NIH Common Fund) supports exceptional junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral and social science research, research on health disparities, novel therapeutics, and other related topics. Awards will be for up to $250,000 in direct costs per year, plus applicable Facilities and Administrative (F&A) costs. The maximum project period is 5 years. Please contact Holly Sommers (hsomme2@emory.edu) if you have any questions. | | | | Read More | | |
| |
| | | | The Alzheimer's Drug Discovery Foundation (ADDF) supports promising research projects from around the world to develop new drugs for Alzheimer's and related dementias, including vascular, Lewy body, and frontotemporal dementias. Four funding opportunities are currently open. The goal is to accelerate the development of therapies through four core areas: Drug discovery, Clinical trials, Biomarkers, and Prevention. Contact your RAS unit and Jessica McDaniel, Jessica.McDaniel@emory.edu, to inform them of your intent to submit. | | | | Read More | | |
| |
| | | | The purpose of this Notice of Special Interest is to highlight the list of widely appreciated systematic barriers or translational science problems included in PAR-19-099 and PAR-19-100 to add the following topics of interest: Rural Health, Racial and Ethnic Disparities in Maternal Mortality, Applications for Machine Learning and Artificial Intelligence (AI), Veterans' Health. | | | | Read More | | |
| |
| | | | The Damon Runyon Fellowship identifies the nation’s top postdoctoral fellows and provides funding that enables them to complete their training under the mentorship of a leading senior scientist and encourages them to follow their own bold ideas. Award up to $100,000 based on stage and scope of research. Per the eligibility requirements for the “Breakthrough Scientist” award is that you must have been previously selected as a DRCRF Fellow between 2016 -2017. | | | | Read More | | |
| |
| | | | NIAMS requests applications for the NIAMS Resource-based Centers Program (P30) for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently funded individual and/or collaborative research projects more efficiently and/or more effectively. Application budgets are limited to $500,000 direct costs per year. The maximum project period is 5 years. | | | | Read More | | |
| |
| | | | 2021 Beckman Young Investigators Program provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences, particularly to foster the invention of methods, instruments and materials that will open up new avenues of research in science. It is open to those within the first three years of a tenure-track position. Please note: Tenure- Track dates for the 2021 program must start after 8/6/2017 AND before 8/6/2020. Tiffany Worboy (tworboy@emory.edu) will coordinate the internal approval needed for submission with the respective Deans’ and the Provost’s Office. | | | | Read More | | |
| |
| | | | We are pleased to announce the launch of the Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional) competition for Emory University investigators. The purpose of this FOA is to solicit applications to participate in a clinical studies program to improve the long-term outcome of adult and pediatric transplant recipients (thoracic organ, abdominal organ, vascular composite tissue, and cellular replacement). | | | | Read More | | |
| |
| | | | Congressional legislation enacted in response to the COVID-19 pandemic includes an emergency appropriation of $306 million to NCI “to develop, validate, improve, and implement serological testing and associated technologies. The goal of the appropriation to NCI is to address the urgent need to increase our understanding of the immune response to the novel coronavirus. NCI intends to use the emergency appropriation in part to establish a Serological Sciences Network (SeroNet). The network is being developed in close collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) and other parts of NIH and the Department of Health and Human Services. | | | | Read More | | |
| |
| | | | The Chan Zuckerberg Initiative invites applications for five-year grants to support the work of Imaging Scientists employed in imaging core facilities at non-profit universities or research institutes across the world. The initiative seeks to support the work of up to 15 Imaging Scientists who will work at the interface of biology, microscopy hardware, and imaging software at imaging core facilities across the world. The primary goal of the program is to increase interactions between biologists and technology experts. The maximum budget that can be requested is $250,000 total costs per year for five years (no more than $1,250,000 total for five years). The award period is three years plus an additional two years, awarded as a separate grant, if the Imaging Program passes a review at year three. Please contact Connor Cook (Connor.Cook@emory.edu) if you have any questions or to inform of your intent to submit. | | | | Read More | | |
| |
| | | | This $4 Million Prize elevates the compelling stories of community members and leaders across the country who are working together to transform neighborhoods, schools, businesses, and more so that the opportunity for better health flourishes for all. Contact Connor Cook at Connor.Cook@emory.edu if you have any questions. | | | | Read More | | |
| |
| | | | The Harry Frank Guggenheim Foundation welcomes proposals from any of the natural and social sciences and the humanities that promise to increase understanding of the causes, manifestations, and control of violence and aggression. The Foundation provides both research grants to established scholars and dissertation fellowships to graduate students during the dissertation-writing year. Highest priority is given to research that can increase understanding and amelioration of urgent problems of violence and aggression in the modern world. Most awards fall within the range of $15,000 to $40,000 per year for periods of one or two years. Please contact your RAS unit and Nicole Dancz (Nicole.dancz@emory.edu) to inform of your intent to submit. | | | | Read More | | |
| |
| | | | The Chan Zuckerberg Initiative invites applications for open source software projects that are essential to biomedical research. Applicants can request funding between $50k and $250k for one year (inclusive of up to 15% for indirect/overhead costs). | | | | Read More | | |
| |
| | | | Proposal deadline has been extended in consideration of the challenges facing many in our country. The Faculty Early Career Development (CAREER) Program is a foundation-wide activity that offers the National Science Foundation's most prestigious awards in support of early-career faculty who have the potential to serve as academic role models in research and education and to lead advances in the mission of their department or organization. NSF encourages proposals from early-career faculty at all CAREER-eligible organizations and especially encourages women, members of underrepresented minority groups, and persons with disabilities to apply. | | | | Read More | | |
| |
| | | | The goal of this $1 Million funding opportunity is to translate and adapt knowledge from around the world to the United States on approaches that can improve health or the determinants of health by improving gender equity. Contact Connor Cook at Connor.Cook@emory.edu if you have any questions. | | | | Read More | | |
| |
| | | | Robert Wood Johnson Foundation seeks proposals that are primed to influence health equity in the future. We are interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, we welcome ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health. | | | | Read More | | |
| |
| | | | The new Georgia CTSA Grant Wise service offers the opportunity for one-on-one feedback from experienced senior faculty on grant writing. We are soliciting experienced faculty to serve as volunteer mentors. If you have experience in writing grants and you enjoy mentoring, we need you! After completing the online volunteer form, we will be in touch should we receive a request that matches your expertise. Contact lauren.james@emory.edu | | | | Volunteer Form | | |
| |
| | | | The COVID-19 Collaboration Platform brings unassociated research teams working on the same clinical research questions together to share protocols, data, and evidence. COVID-19 Collaboration Platform offers support managing collaborations, including expedited and prioritized help from the Trial Innovation Network and SMART IRB to form multi-site trials; expert statistical advice for aggregated analyses, and free data storage and anonymization through vivli.org. | | | | Read More | | |
| |
| | | | The National Center for Data to Health and NCATS are leading the creation of a national, centralized, secure portal for COVID-19 clinical data. The cloud-based collaborative portal will allow for the development of machine learning and other informatics tools that require a large row-level dataset and will be overseen by a data access committee. This portal will provide additional assets needed to rapidly develop the analytics that clinical centers and physicians need now. | | | | Read More | | |
| |
| | | | NCATS web content on the National COVID Cohort Collaborative (N3C) is now available including links to program resources, related funding opportunities, and frequently asked questions. | | | | Read More | | |
| |
| | | | CURE ID is an internet-based repository that lets the clinical community report novel uses of existing drugs for difficult-to-treat infectious diseases through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new treatments for neglected diseases. CURE ID is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). | | | | Read More | | |
| |
| | | | The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world. Learn more about how to request access to resources of the COVID-19 HPC Consortium. | | | | Read More | | |
| |
| | | | Georgia CTSA is now offering Virtual Studios to meet your research brainstorming needs. Our on-site presence has temporarily changed, but our desire to help you plan and collaborate regarding existing and potential research has not paused. Examples of areas where we have served past customers with expert brainstorming include locating collaborators and resources, hypothesis generation, study design, implementation, analysis and interpretation, translation and manuscript development of research topics. Contact the Georgia CTSA Coordinating Center by emailing Karen Lindsley at klindsl@emory.edu or Submit a Request for a Studio Consultation. | | | | Submit a Request | | |
| |
| | | | Authorship: Deciding First Authorship (PDF) | | | | Read More | | |
| |
| | | | What's the answer to your "I wish I had..." or, "What if we could...?" when it comes to your ideas for novel medical device technology? What if you could partner alongside and advise a Georgia Tech Biomedical Engineering (BME) team to investigate and develop a solution for that idea in just 16 weeks? You can! BME Capstone is currently seeking project proposals for the Fall 2020 semester. During GT BME Capstone, each Capstone team works over 500 manhours per project to ideate, design, and prototype real solutions that address unmet clinical needs. If you have identified a health-care challenge that needs to be solved, Capstone teams are eager to work on it. | | | | Read More | | |
| |
| | | | Registration is now open for the SBIR Road Tour stopping at UGA in Athens, GA. National outreach effort connecting entrepreneurs working on advanced technologies to the country’s largest source of early stage funding – the SBIR/STTR programs. Opportunity for small businesses, innovators, researchers, entrepreneurs and technology companies to connect directly with SBIR/STTR program managers representing more than a dozen different federal agencies. SBIR/STTR programs provide over $3.7 billion in funding to small businesses each year in a wide variety of technology areas. | | | | Read More & Register | | |
| |
| |  | | The Georgia CTSA recently partnered with the All of Us Research Program. All of Us is a health research program funded by the National Institutes of Health (NIH). Its goal is to help researchers better understand why people get sick or stay healthy. The mission of the All of Us Research Program is simple: to speed up health research and medical breakthroughs. To do this, All of Us is asking one million people from across the U.S. to share their health ... | | | | Read More | | |
| |
| | | | Please join the Division of Animal Resources via Zoom from 1:00 pm – 2:00 pm for a Division of Animal Resources operations update. | | | | Read More | | |
| |
| | | | Mark your calendar and join us in 2021 as we bring together researchers from across the region to present the best new clinical and translational research and build collaborative partnerships. More information, registration, and call for abstracts will be announced in the coming months. We are closely monitoring the COVID-19 pandemic and will make a decision later this year whether to proceed virtually or in person at Callaway Resort & Gardens. | | | | Read More | | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|
